Sacral dimple: Incidental findings from newborn evaluation (Case Presentation)

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 5, 2009, Pages 768-769

  Ohashi, Amiko ^a   Montaño, Adriana M ^a   Colón, José E ^b   Oguma, Toshihiro ^c   Luisiri, Atchawee ^a   Tomatsu, Shunji ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b St Joseph's Women's Hospital   (United States)

^c DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; KERATAN SULFATE; N ACETYLGALACTOSAMINE 6 SULFATASE;

ARTICLE; BONE DYSPLASIA; BONE MALFORMATION; BONE RADIOGRAPHY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; GENE MUTATION; HUMAN; KYPHOSIS; LABORATORY TEST; MALE; MORQUIO SYNDROME; NEWBORN; NEWBORN ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SACRAL DIMPLE; SPINE MALFORMATION;

EID: 64149126182     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2009.01134.x     Document Type: Article

References (15)

1. Neufeld EF, Muenzer J. The Mucopolysaccharidoses. In Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY : McGraw-Hill, 2001.
2. Montaño AM, Tomatsu S, Gottesman GS, Smith M, Orii T. International Morquio A registry: clinical manifestation and natural course of Morquio a disease. J Inherit Metab Dis 2007 30 : 165 74.
3. Whitley CB, Spielmann RC, Herro G, Teragawa SS. Urinary glycosaminoglycan excretion quantified by an automated semimicro method in specimens conveniently transported from around the globe. Mol Genet Metab 2002 75 : 56 64.
4. Harangi F, Györke Z, Melegh B. Urinary glycosaminoglycan excretion in healthy and stone-forming children. Pediatr Nephrol 1996 10 : 555 8.
5. Huang KC, Sukegawa K, Orii T. Screening test for urinary glycosaminoglycans and differentiation of various mucopolysaccharidoses. Clin Chim Acta 1985 151 : 147 56.
6. Tomatsu S, Okamura K, Taketani T, Orii KO, Nishioka T, Gutierrez MA, et al. Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA. Pediatr Res 2004 55 : 592 7.
7. Tomatsu S, Okamura K, Maeda H, Taketani T, Castrillon SV, Gutierrez MA, et al. Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses. J Inherit Metab Dis 2005 28 : 187 202.
8. Oguma T, Tomatsu S, Okazaki O. Analytical method for determination of disaccharides derived from keratan sulfates in human serum and plasma by high-performance liquid chromatography/turbo-ionspray ionization tandem mass spectrometry. Biomed Chromatogr 2007 21 : 356 62.
9. Kriss VM, Desai NS. Occult spinal dysraphism in neonates: assessment of high-risk cutaneous stigmata on sonography. AJR Am J Roentgenol 1998 171 : 1687 92.
10. Mabe P, Valiente A, Soto V, Cornejo V, Raimann E. Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and Berryspot tests. Clin Chim Acta 2004 345 : 135 40.
11. Björnsson S. Quantitation of proteoglycans as glycosaminoglycans in biological fluids using an alcian blue dot blot analysis. Anal Biochem 1998 256 : 229 37.
12. Piraud M, Marie I, Mathieu M. Pitfalls of screening for mucopolysaccharidoses by the dimethylmethylene blue test. Clin Chem 1993 39 : 163.
13. Dembure PP, Roesel RA. Screening for mucopolysaccharidoses by analysis of urinary glycosaminoglycans. In : Hommes FA, editor. Techniques in Diagnostic Human Biochemical Genetics-A laboratory manual. New York, NY : Wiley-Liss, 1991.
14. de Jong JG, Heijs WM, Wevers RA. Mucopolysaccharidoses screening: dimethylmethylene blue versus alcian blue. Ann Clin Biochem 1994 31 : 267 71.
15. Tomatsu S, Montaño AM, Nishioka T, Gutierrez MA, Peña OM, Trandafirescu GG, et al. Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A). Hum Mutat 2005 26 : 500 12.